Panels


Panel 1
Beyond Blockbusters: The Future of the Pharmaceutical Industry

This panel will look at the impact of impending patent cliffs on several high profile drugs, discuss the pharmaceutical industry’s shift in focus toward “niche” drugs and personalized medicines, and explain how this new strategy will impact the future of the pharmaceutical industry and overall healthcare delivery.



Tim Calkins is a clinical professor of marketing at Northwestern University's Kellogg School of Management, where he teaches marketing strategy, biomedical marketing and strategic marketing decisions in the full-time, part-time and executive MBA programs. He is co-academic director of Kellogg's branding program.


Tim has received numerous teaching awards, including two Kellogg Faculty Impact Awards, four Top Professor Awards from the Kellogg Executive MBA, the Sidney J. Levy Teaching Award and the Lawrence G. Lavengood Outstanding Professor of the Year Award, the top teaching award at Kellogg.


He is the author of Defending Your Brand: How Smart Companies Use Defensive Strategy to Deal with Competitive Attacks (Palgrave Macmillan, 2012) and Breakthrough Marketing Plans (Palgrave Macmillan, 2008 and 2012). He is co-editor of Kellogg on Branding (John Wiley & Sons, 2005). Tim has also published more than a dozen Kellogg case studies.


In addition to teaching at Kellogg, Tim works with major corporations around the world on strategy and branding issues. He is managing director of Class 5 Consulting, a marketing strategy firm. Tim is frequently cited by the media; he has been quoted in publications including Business Week, Newsweek, the Financial Times, The Wall Street Journal and The New York Times. He has appeared on NBC, CBS, ABC, Fox, and CNBC.


Tim serves on the board of the Chicago Business Marketing Association, the Alliance Française de Chicago and the Lycée Français de Chicago, Chicago’s French-International School. He received his BA from Yale and his MBA from Harvard.



Chris Wright is the Managing Director of ZS Associates and is based in Evanston, Illinois. Previously, he served as the leader of ZS's global Pharmaceuticals practice and as regional lead for the firm’s offices in the Midwestern and Western U.S.


He has experience in an extensive range of sales and marketing issues in the pharmaceuticals and health care industries. For almost 25 years, Chris has helped over 100 operating affiliates of top global companies develop and implement sales force sizing, structuring and resource allocation decisions. His international experience includes engagements across North America, South America, Europe, Australia, Asia and Africa.


Chris has a B.S. in accounting from Indiana University, and an M.B.A. with honors from the Kellogg School of Management at Northwestern University.


Chris was recognized as one of Consulting Magazine’s Top 25 Consultants in 2009 for his innovative work to improve sales force effectiveness in the pharmaceutical industry.


He is a frequent contributor to prominent healthcare publications (including PharmaVOICE, Med Ad News, Pharmaceutical Commerce, FiercePharma and Medical Marketing & Media), as well as leading business media such as The Wall Street Journal.



James J. Gillespie, Ph.D., is President & CEO of the Center for Healthcare Innovation (www.chisite.org), a 501(c)(3) research center and thought-leadership institution focusing on the global life sciences industry. He is a scholar, executive, and entrepreneur, with an expertise focusing on the strategy, analytics, and operations of the biotechnology, medical device, and pharmaceutical sectors. Mr. Gillespie is also CEO and Managing Director of the Chicago Life Sciences Consortium, a resource for biopharmaceutical, medical device, and healthcare companies in the metropolitan Chicago area. Mr. Gillespie is Founder & Co-Leader of the Working Group on Innovation & Interoperability, a healthcare analytics project featuring executives from several prominent healthcare institutions. Mr. Gillespie’s research has appeared in Academy of Management Review, American Behavioral Scientist, European Journal of Social Psychology, Federal Reserve Bank, Harvard Business Review, and Strategic Management Journal. His education includes Northwestern University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; and Carnegie Mellon University.



John received a BA in Economics from DePauw University and an MBA from the University of Miami. He was been with Eli Lilly for 27 years and has held 11 roles, primarily in Marketing, in the US, Spain, South Korea, and Australia. John was the US Brand Leader who with his team launched Cymbalta for major depressive disorder and diabetic peripheral neuropathic pain. He currently leads a team of marketers who partner with Lilly Research Laboratories' discovery scientists and physicians.



Matthew Hudes is the U.S. Managing Principal, Biotechnology, for Deloitte’s Health Sciences practice. In this role, he develops, provides and leads the practice’s professional services, working with Tax, Audit and Enterprise Risk, Consulting, and Financial Advisory Services, for this dynamic industry sector. Deloitte’s practice is recognized as the leading full-scope professional services firm in the Life Sciences sector.


Previously, he was the Chairman and CEO of Accélère, a software company that developed a system to find patients (and investigators) for clinical trials and to improve researchers’ access to information typically “trapped” in laboratory and medical systems.


Matthew has provided strategic professional services to leading Biotechnology, Pharmaceutical, and Medical Device companies, as well as Academic Research Centers. He speaks frequently about such topics as fostering innovation, personalized medicine, the use of technology for innovating clinical research, finance transformation, manufacturing and quality, regulatory compliance, and supply chain. He is a faculty member and executive sponsor of the UC Berkeley BioExec Institute, a member of the Advisory Board of the California Institute for Quantitative Biosciences (QB3), and he is the executive sponsor of Deloitte’s unique innovation collaboration with the University of California.


Formerly, Matthew led the global Capgemini Life Sciences Biotechnology and R&D practice. As a former Partner with Ernst & Young LLP, he acted as a strategic advisor to leading-edge companies in Life Sciences and Technology over a period of more than 17 years.


Matthew received an MBA from Santa Clara University and a BA from the University of Connecticut.




Panel 2
Expanding Population-Based Care: Payers, Providers, and Accountable Care Organizations

The borders of provider health systems are expanding to include functions previously managed by insurers, IT providers and other specialists. This panel will discuss how the newly codified accountable care organizations (ACO) model shifts the provider-focus from procedural volume to population management, and how this shift affects other players in the continuum of healthcare services. Panelists will also explore the outcomes observed in the first wave of ACOs and share insights on how the model can be refined and changed.



David Dranove is the Walter McNerney Professor of Health Industry Management at Northwestern University's Kellogg School of Management, where he is also Professor of Management and Strategy. He has a PhD in Economics from Stanford University.


Professor Dranove’s research focuses on problems in industrial organization and business strategy with an emphasis on the health care industry. He has published nearly 75 research articles and book chapters and written five books, including The Economic Evolution of American Healthcare and What’s Your Life Worth? His textbook, The Economics of Strategy, is used by leading business schools around the world. His latest book, Code Red, was published by Princeton University Press in 2008.



Dr. Sikka is Vice President of Clinical Transformation for Advocate Health Care. He leads and develops Advocate’s health outcomes programs, services and performance standards. He has system medical and administrative oversight of health outcomes, clinical operations and business intelligence.


Dr. Sikka received his bachelor of science in economics from the Wharton School at the University of Pennsylvania. He received his medical degree from Mayo Medical School in Rochester, MN. He completed his internship in internal medicine at St. Vincent's Hospital, NY and his residency in emergency medicine at Boston Medical Center.


During his time at Boston Medical Center, Dr. Sikka was the recipient of the Frommer Academic Excellence Award, New England Research Directors Excellence in Research Award and the Outstanding Faculty Teaching Award.


Dr. Sikka continues to practice emergency medicine and is a clinical associate professor in the Department of Emergency Medicine at the University of Illinois-Chicago, School of Medicine.


Brigitte Nettesheim is the Head of Strategy and Operations for the West and Mid America Regions in Aetna’s Accountable Care Solutions organization, responsible for working directly with providers of healthcare services to design and build new care and reimbursement models that deliver value in the market. Brigitte has held multiple roles during her seven years with Aetna. Most recently she led a successful national initiative to improve the underlying cost structure of Aetna’s health insurance products. Brigitte previously served as the Director of Sales and Service, working directly with large employers to align their benefit strategies with impactful outcomes and as the Director of Medical Economics for Aetna’s Mid America Region.


Prior to her work at Aetna, Brigitte was a provider strategy consultant with Tiber Group (now owned by Navigant Consulting) where she worked on multiple strategic initiatives with providers across the nation. She also formerly worked on business development in the Specialty Pharmacy division of Caremark and spent five years as an active duty officer in the U.S. Army.


Brigitte holds a B.S. in Economics from the United States Military Academy at West Point and a M.B.A. with emphasis in Health Industry Management from Northwestern University’s Kellogg School of Business. Brigitte and her husband Dan reside in Kenilworth, Illinois, with their three children where she is actively involved in the community and coaches a competitive level girls fastpitch softball team.



Peg Mason owns healthcare quality improvement. She brings over 30 years of experience in healthcare quality improvement, patient safety, population health management and provider consulting, as well as technical assistance for creating and validating healthcare quality measures. Peg is recognized nationally for her leadership in healthcare quality, including her involvement with the federal QIO program and leadership in the CMS hospital public reporting program at its inception. Peg oversees Telligen's health management solutions for commercial payers, Medicaid and Medicare programs. Peg holds designations of Registered Health Information Technician from the American Health Information Management Association; Certified Professional in Health Care Quality from the Healthcare Quality Certification Board; and Population Health Certificate Program from the Population Health and Care Coordination Colliquium. Peg also previously served on the American Health Information Management Association's Practice Council on Quality Initiatives and Secondary Data and as a member of the Utilization Review Accreditation Commission's Health Standards Committee.




Case Study 1
Market Access in Emerging Markets

In an ever-changing healthcare environment and increased price pressure domestically, emerging markets are a key area for strategic growth. This session will take an in-depth look at case studies of medical device companies who have grown their business in BRIC economies, what business leaders have done to successfully satisfy consumer needs in those markets and other lessons learned.


Professor Garthwaite joined the faculty at the Kellogg School of Management in 2009. He is an applied microeconomist whose research focuses broadly on public economics, health economics, and political economy. His recent projects have examined the economic benefits of health care innovations and the effect of Oprah Winfrey’s endorsement of now-President Barack Obama during the 2008 Democratic Presidential primary.


Garthwaite received a B.A. and a Masters in Public Policy from the University of Michigan. Prior to receiving his PhD in Economics from the University of Maryland, he served in a variety of public policy positions including the Director of Research for the Employment Policies Institute. He has testified before the United States House of Representatives and several state legislatures on matters related to the minimum wage and health care reforms.



Brian joined Baxter International as Global Franchise Head for Hemophilia in June 2012. Previously, Brian was Vice President and Head of the Primary Care Business Unit in the US for Novartis Pharmaceuticals Corporation. Brian held several key leadership positions at Novartis, including global brand leadership in Basel, Switzerland. Before joining Novartis in 2005, Brian spent 14 years in key positions in sales and product management in the pharmaceutical division of Johnson & Johnson. Brian has a BA, Phi Beta Kappa in Economics from Skidmore College and an MBA from the Wharton School of Business of the University of Pennsylvania. Brian lives in the Chicago area with his wife and four children.



Chris O’Connell was named Executive Vice President and President for the Restorative Therapies Group in August, 2009, with global responsibility for the company’s Spine, Neuromodulation, Surgical Technologies and Kanghui Orthopedics business units. Chris provides overall strategic direction and operational oversight for this Group of related businesses, as well as leading the integration of the Group’s activities within the overall strategy of Medtronic.


Chris joined Medtronic in 1994 and has held a variety of leadership positions within the company. Most recently, Chris served as Senior Vice President and President of the Diabetes business, based in Northridge, California. Previously, he served as President of Medtronic Physio-Control, based in Redmond, Washington. He has also held key leadership positions in the company’s Cardiac Rhythm Disease Management business, including Vice President of Sales and Marketing, and Vice President/General Manager of the Patient Management Business. In addition, Chris led key corporate functions as Vice President of Corporate Strategy, and Director of Investor Relations. He began his Medtronic career in Corporate Development.


Before joining Medtronic, Chris worked for the Corporate Finance unit of Chemical Bank. Chris earned a bachelor’s degree from Northwestern University in 1989 and a master’s degree in business administration from Harvard University in 1994.



Renuka Gadde is Vice President, Global Health, at BD. Renuka provides overall leadership for BD’s global health activities in emerging and developing countries. Among her key areas of responsibility is extensive external engagement with ministries of health, international agencies and non-government organizations, and significant internal engagement across BD’s units, geographies and functions in support of the Company’s strategies, products and programs that advance global health needs and efforts. Renuka also works across businesses for market assessment and development for global health-related products and technologies, and on advocacy and policy, public-private partnerships and engagement with global and local funding organizations.


Renuka joined BD in 1997 and relocated to the US in 2002 in the position of Director, Strategic Planning and Development for BD Medical. In 2004, she became the global leader for Immunization and Injection Safety, responsible for our auto-disable and reuse prevention product lines, and also serving as BD’s Key Account Manager with UNICEF. In 2008, Renuka moved to Preanalytical Systems as Senior Director, Global Health. In this role, she was responsible for safe blood drawing initiatives and product development for developing and emerging markets.


Throughout several of her previous positions, Renuka was instrumental in establishing collaborative initiatives with organizations such as the President’s Emergency Plan for AIDS Relief (PEPFAR) and the International Council of Nurses.


Renuka represents BD in several external speaking engagements. She is on the board of ASLM (African Society of Lab Medicine). She is also the board alternate for the private sector delegation of the Global Fund.




Case Study 2
Technology Showcase: Centering Healthcare’s Focus on the Patient

New technologies are enabling patients to have increased access to healthcare—from where they live to what they wear on their bodies. This session will showcase companies with innovative technologies that are disrupting healthcare and growing a fast following.



Wendy combines her expertise in both healthcare and technology to create novel solutions that will be impactful for patients, clinicians, and consumers. Most recently, she led the Center for Healthcare Innovation at Catholic Health Initiatives (CHI) where her team designed and led prototype projects to enable the process of creating and adopting new care delivery models. Prior to joining CHI, Wendy was responsible for accelerating innovation and driving growth in new markets at Cisco and Palm, leading various initiatives in venture capital investments, technology licensing, and corporate partnering. She also led strategic planning and business development roles at leading healthcare device companies, including Baxter and Becton Dickinson. She has an undergraduate degree in biology from Amherst College and an MBA from the Kellogg School of Management.



Charlie Huiner has served as the Vice President Business Development for InTouch Health since 2007. During this time InTouch Health has been recognized by Deloitte as one of today's 500 fastest growing technology companies and by Inc. Magazine as one of the 500 fastest growing companies and top 100 health companies in America. Mr. Huiner is a seasoned business development and marketing executive with a track record of identifying gaps and opportunities in corporate strategy and creating actionable plans for business transformation. He has led the sourcing, structuring and negotiation of over $11 billion in acquisitions and $160 million in licensing and partnership transactions and is frequently invited to speak at noteworthy healthcare technology meetings and events. Mr. Huiner received his MBA in finance and marketing with a concentration in healthcare management from Northwestern University’s Kellogg School and a BA from Williams College.



Jeff is an entrepreneur at heart with a lifelong passion for creating innovative and human-powered companies. This fundamental belief in the potential of those around him led to a career in the talent management field, where he was Founder and CEO of three internet-based services companies. He served as SVP of Sales & Marketing for Ameritox, a private equity-owned healthcare services company, and before that he was the first VP of Marketing at Dyson – makers of awesome consumer products. Jeff is an active member in Young Presidents' Organization (YPO). He holds a BS from The Wharton School at University of Pennsylvania and an MBA from The Kellogg Graduate School of Management at Northwestern University.



Jordan Dolin is the Founder of Emmi Solutions, a healthcare information technology company. The Company creates multi-media patient engagement solutions that are leveraged by leading hospitals and healthcare organizations nationwide to improve clinical and financial outcomes. The programs created by Emmi Solutions address the serious issues facing the US healthcare system; increasing financial pressures coupled with a growing lack of resources. Emmi pioneered the concept of “Outcomes-Driven Engagement” and continues to be recognized as the market leader in patient engagement. Over 6 million patients have been prescribed an Emmi program and through the Company’s patented platform, clients have the ability to track the impact all the way down to the individual patient level. Over 11 years Emmi has grown from a single employee to well over 100 and is on the INC5000 list of the fastest growing American companies. Jordan is a frequent speaker on the topics of patient engagement and entrepreneurialism and has 25 years experience starting and running companies. He is also an active member of the Chicago entrepreneurial community, serving as a mentor at several of the incubators and is also an adjunct professor at University of Chicago's Booth Graduate Business School. He holds a BA in Marketing from the University of Wisconsin at Madison and a Masters Degree from Northwestern University’s Medill School of Journalism’s Integrated Marketing and Communications program. Jordan is also a member of the Economic Club of Chicago. He and his wife, Jenny, have 3 sons, Henry, Charlie and Cooper




Panel 3
Beyond Hospitals: The Future Sites of Healthcare Delivery

Healthcare delivery services are proliferating beyond the more traditional walls of hospitals and primary care doctor’s offices. The panel will look at new sites of healthcare delivery, such as “minute-clinics” and “concierge” doctor’s offices, which are redefining healthcare delivery by reducing costs, increasing access or improving care.



Leemore Dafny is a Professor of Management and Strategy and the Herman Smith Research Professor in Hospital and Health Services at Northwestern University’s Kellogg School of Management. Her research examines competitive interactions among payers and providers of healthcare services, and the intersection of industry and public policy. Dafny’s work has been published in journals such as the American Economic Review and the New England Journal of Medicine, and featured in The New York Times, BusinessWeek, Bloomberg, and The Washington Post.


Dafny graduated summa cum laude from Harvard College and worked as a consultant with McKinsey & Company prior to earning her PhD in economics from the Massachusetts Institute of Technology. She has won several teaching awards as well as Kellogg’s leading research prize, the Stanley Reiter Best Paper award. Dafny is a Research Associate of the National Bureau of Economic Research, a Faculty Fellow at Northwestern’s Institute of Policy Research, and a Board member of the American Society of Health Economists.


Dafny’s expertise spans both the public and private sectors. She has served on the Panel of Health Advisers for the Congressional Budget Office and Mayor Rahm Emanuel’s Retiree Health Benefits Commission. In 2012-2013, she took academic leave to assume the role of Deputy Director for Healthcare and Antitrust in the Bureau of Economics at the Federal Trade Commission in Washington, DC. Dafny regularly advises companies, government agencies, and nonprofits on a variety of issues including antitrust matters, strategic decisions, and public policy.



Mr. Dragan Djordjevic is an internist in private practice at Rush University Medical Center. He is also an Assistant Professor of Medicine at Rush University. He has been a practicing physician for 18 years, and became affiliated with MDVIP, a personalized healthcare company, in 2007. Dr. Djordjevic has served as the Team Physician for the Chicago White Sox (2004-2009). He has been named one of the Best Doctors in America (2007-2013), and has received an Outstanding Teacher Award. Mr. Djordjevic received his BA in Biology from the University of Chicago and his Medical Doctorate from Rush University, where he also completed his residency.



Mr. Duncan is Vice President, Clinical Research & Reporting at the Walgreen Company, responsible for Walgreens clinical outcomes, research and publications, client analytics and reporting and actuarial functions. He is also an Adjunct Professor of Actuarial Statistics at the University of California Santa Barbara, and an Adjunct Research Professor in the Dept. of Healthcare Administration at Georgetown University. The founder of Solucia Consulting, a provider of analytical and consulting services to the healthcare financing industry, he retired in 2010. Mr. Duncan holds a post-graduate degree in economics from Balliol College, Oxford, and is a fellow of the Society of Actuaries (US), the Institute of Actuaries (London) and the Canadian Institute of Actuaries. He is active in public policy and healthcare reform, and serves on the boards of directors of the Commonwealth of Massachusetts Health Insurance Connector Authority, the Society of Actuaries and the Healthcare Informatics advisory board of Bryan University, Tempe AZ. He is the author of approximately 40 peer-reviewed papers, and several books and book chapters. His last book “Healthcare Risk Adjustment and Predictive Modeling” (Actex Publications) was published in May 2011, and a new edition of “Managing and Evaluating Healthcare Intervention Programs” is due to be published in October.



Mr. Coloton is an Executive Vice President and Partner at Clinovations. With more than 15 years of experience in healthcare clinical practice, consulting, hospital administration, and healthcare technology, Mr. Coloton leads the strategic and operational management of the firm, as well as the Ambulatory Service line. His experience and expertise ranges from healthcare strategic planning to hospital/clinic operations and technology design and implementation. Mr. Coloton was recently honored as a winner in SmartCEO Magazine’s 2013 Executive Management Awards.


Prior to joining Clinovations, Mr. Coloton was responsible for the healthcare technology portfolio at a Target Corporation. He has significant management consulting experience, having served as the strategic advisor to hospitals and health systems nationwide. Mr. Coloton’s expertise also includes EHR and Revenue Cycle system selection, design, and implementation. He brings a multifaceted knowledge of the healthcare industry from his former experiences as a Hospital Executive at Johns Hopkins, a physical therapist, and an employee of a premier healthcare think-tank based in Washington.


Mr. Coloton is a Fellow in the American College of Healthcare Executives, former president of the Maryland Association of Healthcare Executives, and an active member in the Health Care Information and Management Systems Society (HIMSS). Mr. Coloton holds a Master in Business Administration from Johns Hopkins Carey School of Business in Baltimore and a Master of Physical Therapy in Healthcare from the University of the Sciences in Philadelphia.



Mr. Malkin graduated with a BS from the University of Illinois, Urbana 1983. He attended medical school at Rush University, graduating in 1987, followed by an internship and residency in Internal Medicine at Michael Reese Hospital and Medical Center, finishing in 1990. Dr. Malkin joined the Medical Care Group in 1990, practicing primary care internal medicine through the present, although now part-time. He holds admitting privileges at Northwest Community Hospital and Alexian Brothers Medical Center. Currently, Dr. Malkin works full-time for AIM Specialty Health as a senior physician reviewer for high tech imaging and sleep medicine.


Dr. Malkin is the past President of the Chicago Medical Society, 2005-2006 and the past President of the Illinois State Medical Society 2010-2011. Dr. Malkin is currently in his second term as Board Chair of the Illinois State Medical Society. He also serves as an Alternate Delegate for the American Medical Association.




Panel 4
The Shifting Landscape of Healthcare Investing: Strategic Investors and Incubators

Early-stage investing in healthcare technologies has traditionally been dominated by venture capital firms and academia. In recent years, early-stage incubators have become increasingly prevalent, and corporations—insurers, health systems, manufacturers—are establishing corporate venture arms. The panelists will explore the types of innovations that are being funded and how this shift impacts the investment landscape.



Professor William P. Sutter, Jr. is a Senior Lecturer of Finance and a member of Kellogg's Larry and Carol Levy Institute for Entrepreneurial Practice. He teaches Venture Capital and Private Equity – The Human Element (ENTR 926), NUvention Medical Innovation (HEMA 915), and Global Governance of Private Companies (ENTR 965). Professor Sutter is a founder of Wildcat Angels and manages the student Associates program for screening deal flow.


Professor Sutter is also a Partner of Hopewell Ventures, a $106 million venture capital fund with an investment focus on high-growth companies located in the Midwest. Hopewell has completed fifteen investments ranging from medical device manufacturers to alternative media companies.


Before becoming a founder of Hopewell, Professor Sutter was a Senior Managing Director of Mesirow Financial's Private Equity division. During his 17-year tenure, capital under management grew to $300 million, and his successful track record comprised investments in 29 portfolio companies, including four that completed an IPO. He started his career as an investment banker with the Corporate Finance department of Smith Barney.


Professor Sutter graduated from Yale University with a B.A. degree in Economics and received his M.B.A. from Stanford University. His interests include scuba diving, military history, and blues guitar.



Tom Hawes is a Managing Director of the BlueCross BlueShield Venture Fund. He serves on the Board of Directors of Patientco, HeartFlow, Nexidia, InVivoLink, Phreesia, and Wellspring Healthcare.


Before joining Sandbox, Tom matched at Yale School of Medicine for residency and completed his first year of medical training at Greenwich Hospital. During his medical training, he worked on clinical studies at the ISK Institute for Orthopaedics and Sports Medicine and on outcomes research at the National Cancer Institute and NYMC’s Cardiothoracic Surgery Department. Tom is on the National Advisory Board of the Desmoid Tumor Research Foundation.


Tom holds a BA from Brigham Young University, an M.D. from New York Medical College and an MBA from Harvard Business School. He is also a Kauffman Fellow.



Mohit Kaushal is the newest member of the Aberdare team, joining as a partner in 2013. Mohit has had an extensive career within clinical medicine, venture capital and health policy. He was most recently the inaugural Chief Strategy Officer and Executive Vice President of Business Development at West Health a unique set of entities focused on lowering health care costs through medical research, healthcare policy and investment. He developed the West Health Investment Fund strategy, sourced and led investments in Humedica (acquired by Optum Health), Change Healthcare, RxAnte and goBalto.


Previously, Mohit was the Director of Connected Health with the Federal Communications Commission, where he established the agency’s first dedicated health care team. During his time in the Obama administration, he was also a member of the White House Health IT task force, a cross agency team focusing on implementing the technology aspects of Health Reform. Prior to this position, Kaushal was an investment professional at Polaris Venture Partners, and worked for Merrill Lynch’s Health Care Investment Banking Group and the World Health Organization. Kaushal holds an MBA from Stanford and an MD with distinction from Imperial College, London.


In addition to his role at Aberdare Ventures, Mohit is an Adjunct Assistant Professor of Emergency Medicine at George Washington University and serves on the curation team at TEDMED. He has been appointed to the Consumer Technology Workgroup of the Health IT Standards Committee and to the National Committee on Vital and Health Statistics advising HHS on Data Access and Use.


Lucian is an Investment Manager at Qualcomm Ventures, who makes investments through Qualcomm’s Life Fund. His background and experience in medicine lead him to believe that this is a transformative period in the healthcare space, especially given the renewed interest in performance and cost metrics prevalent today. In this context, Lucian is focused on wireless healthcare opportunities, with a particular interest in early stage investments.


Previously, Lucian worked at McKinsey & Company, where he spent most of his time in the North American healthcare practice advising on clinical and business model transformation for large hospital systems. Prior to McKinsey, Lucian was a board certified internal medicine doctor practicing in New York.


Lucian trained in internal medicine at Columbia University Medical Center in New York and completed both medical school and his undergraduate studies at Tufts University.



Mr. Ryan L. Schuler is a Managing Director at Ascension Health Ventures, LLC. Mr. Schuler joined the firm in 2002 and focuses on investments in the healthcare services sector. Previously, he was an Investment Associate at the firm. Mr. Schuler joined AHV from the investment banking division at A.G. Edwards & Sons, where he served as an Analyst in the firm's mergers and acquisitions group and previously as a Real Estate Analyst in its corporate finance group. Prior to that, Mr. Schuler was an Associate in transaction support and audit practices at PricewaterhouseCoopers, where he began his career. Mr. Schuler is a Board Member or Observer of several AHV portfolio companies including Aethon, Haven Behavioral, Impulse Monitoring, NaviHealth, Solstas, and SterilMed. He was a Director of SeQual Technologies, Inc. Mr. Schuler holds an M.B.A., with honors, from The Olin School of Business at Washington University in St. Louis and a B.S. in Accounting from Christian Brothers University.